Has Aurobindo Pharma declared dividend?
Aurobindo Pharma has declared a 400% dividend, amounting to ₹1.5 per share, with an ex-date of August 8, 2025. While recent total returns have been negative, longer-term performance shows positive growth.
Aurobindo Pharma Ltd. has declared a 400% dividend.Dividend Details:
- Percentage announced: 400%
- Amount per share: 1.5
- Ex-date: 08 Aug 25
Dividend Yield: 0%
Total Returns by Period:
In the last 3 months, the price return was -11.42%, the dividend return was 0.35%, resulting in a total return of -11.07%.
Over the last 6 months, the price return was -9.43%, the dividend return was 0.34%, leading to a total return of -9.09%.
For the 1-year period, the price return was -23.64%, the dividend return was 0.27%, culminating in a total return of -23.37%.
In the 2-year span, the price return was 27.44%, the dividend return was 0.98%, resulting in a total return of 28.42%.
During the last 3 years, the price return was 88.69%, the dividend return was 2.08%, leading to a total return of 90.77%.
Over the past 4 years, the price return was 19.06%, the dividend return was 2.68%, resulting in a total return of 21.74%.
In the 5-year period, the price return was 17.94%, the dividend return was 2.84%, culminating in a total return of 20.78%.
Overall, Aurobindo Pharma has declared a significant dividend, but the recent total returns indicate a mixed performance, particularly in the short term, with negative returns over the last year. However, the longer-term returns show positive growth, suggesting potential recovery and value for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
